MiRNA-139-3p inhibits malignant progression in urothelial carcinoma of the bladder via targeting KIF18B and inactivating Wnt/beta-catenin pathway : Pharmacogenetics and Genomics

Secondary Logo

Journal Logo

Original Articles

MiRNA-139-3p inhibits malignant progression in urothelial carcinoma of the bladder via targeting KIF18B and inactivating Wnt/beta-catenin pathway

Zhang, Wenbina; Liu, Zhihuab

Author Information
Pharmacogenetics and Genomics 33(1):p 1-9, January 2023. | DOI: 10.1097/FPC.0000000000000485

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid